OSLO, Norway, March 29, 2023 /PRNewswire/ — Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals and pharmacies, has today submitted a cash offer to acquire all shares in Sensidose AB (‘Sensidose’) for approximately SEK 75 million (the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.